Doheny Asset Management’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
Other funds holding KYNB
FCM
Doheny Asset Management's KYNB Position: Q3 2021 in Review
Doheny Asset Management sold out of Kyntra Bio (KYNB) in Q3 2021, closing a stake of 322 shares — an estimated $214K sold.
Doheny Asset Management first reported a position in KYNB in Q2 2016 and held it in 21 quarters. The position peaked at $3.86M in Q1 2018. 164 funds tracked by Wall St. Rank hold KYNB as of Q3 2021.
- Doheny Asset Management reported no remaining Kyntra Bio position as of Q3 2021 after selling out during the quarter.
- Doheny Asset Management sold 322 Kyntra Bio shares in Q3 2021, an estimated $214K.
- Doheny Asset Management first reported a position in Kyntra Bio in Q2 2016 and held it in 21 quarters.
- Doheny Asset Management's Kyntra Bio position peaked at $3.86M in Q1 2018.
- 164 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2021.
Based on Doheny Asset Management's 13F filing for Q3 2021, filed 22 Oct 2021.